Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2019 | Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)-Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study | JOURNAL OF THORACIC ONCOLOGY |